Immunohistochemistry studies have shown that mesothelin is expressed in virtually all mesotheliomas and pancreatic ductal adenocarcinomas, a high percentage of epithelial ovarian cancers, and non-small cell carcinomas of the lung [6–10]. Here, MSLN is linked to mesothelioma.